Mechanisms of Fatal Cardiotoxicity following High-Dose Cyclophosphamide Therapy and a Method for Its Prevention

• Takuro Nishikawa ,

  Contributed equally to this work with: Takuro Nishikawa, Emiko Miyahara

  * E-mail: adu44150@ams.odn.ne.jp

  Affiliation Department of Pediatrics, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan

  ⨯
• Emiko Miyahara ,

  Contributed equally to this work with: Takuro Nishikawa, Emiko Miyahara

  Affiliation Department of Pediatrics, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan

  ⨯
• Koichiro Kurauchi,

  Affiliation Department of Pediatrics, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan

  ⨯
• Erika Watanabe,

  Affiliation Department of Clinical Pharmacy and Pharmacology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan

  ⨯
• Kazuro Ikawa,

  Affiliation Department of Clinical Pharmacotherapy, Hiroshima University, Hiroshima, Japan

  ⨯
• Kousuke Asaba,

  Affiliation Clinical Development Dept. 1, Clinical Development Division, EPS Corporation, Saitama, Japan

  ⨯
• Takayuki Tanabe,

  Affiliation Department of Pediatrics, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan

  ⨯
• Yasuhiro Okamoto,

  Affiliation Department of Pediatrics, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan

  ⨯
• Yoshifumi Kawano

  Affiliation Department of Pediatrics, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan

  ⨯